VeriSIM Life is building AI enabled biosimulation models. VeriSIM will tackle one of the biggest obstacles of drug development: animal testing for drug development. Animal testing is slow, ethically questionable, and doesn't act as much of a filter: 92% of all drug candidates that pass this preclinical testing never make it to market.
VeriSIM's solution is to create disease-specific biosimulation models, which allow researchers at pharma companies to model in software how a drug will interact in animals. This will allow researchers to test 1000x more potential candidates in the same unit of time, ensuring that drugs that do make it to (human) clinical trials are far more likely to work, and therefore saving millions in annual costs.
B2B
1 to 25
Series A
$21.7 M
Scaling Up
2017
Pharmaceuticals and Medical Products
Healthcare
Biotechnology
Improve Efficiency & Accuracy
Increase Human Life Expectancy
Increase Efficiency
Risk (AML, Fraud)
Service
Yes
Active
Machine Learning
N/A
Software
N/A
Technical Sales Representative
San Francisco, California
Senior Scientist - Modeling & Simulation
San Francisco, California
Associate Director
San Francisco, California
AI/ML Professionals
Want to work at VeriSIM Life?
We can introduce you to the right person at VeriSIM Life
7
1
$15M
Company was founded 2017 and it took almost 5 years (Jan 2022) to raise first external round
Investors
Interested in researching VeriSIM Life?
We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about VeriSIM Life
Potential Customers
Interested in what they do or partnership?
Learn more about how they work